Therapeutic Potential of Cannabidiol in Dysbiosis-Related Oral Biofilm Diseases: Antibiofilm, Antivirulence and Host Response Evidence
Open Access
- 3 August 2026
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (8) , 1221
Abstract
Dysbiosis-related oral biofilm diseases, particularly dental caries and periodontal diseases, pose major global health challenges because ecological shifts within oral microbial communities enhance biofilm virulence, resilience, and host inflammatory responses. Cannabidiol (CBD), a non-psychoactive phytocannabinoid with antimicrobial, antibiofilm, immunomodulatory, and antioxidant properties, has attracted increasing interest as an investigational, ecology-oriented adjunct for oral health applications. This narrative review evaluates current antibiofilm, antivirulence, and host response evidence for CBD in dysbiosis-related oral biofilm diseases, with emphasis on dental caries and periodontal diseases and selected supportive evidence from other oral biofilm-associated conditions. Current evidence suggests that CBD can inhibit biofilm formation, attenuate cariogenic and fungal virulence traits, modulate periodontal inflammation and immunity, and support tissue-protective responses. However, most evidence remains preclinical and model-dependent, particularly in caries research, and CBD’s hydrophobicity, limited stability, uncertain dose windows, and incomplete microbiome-level evidence remain major barriers to translation. Future studies should clarify CBD’s ecological effects on oral microbial communities, define clinically relevant dosing and exposure timing, and develop oral-retentive delivery systems.Keywords
Funding Information
- Foundation of Science & Technology Department of Henan Province of China (232102310320)
- Foundation of Science & Technology Department of Henan Province of China (242102310376)
- Natural Science Foundation of Education Department of Henan Province (25A320004)
- Foundation of the Science and Technology Department of Kaifeng City of Henan Province (2203015)
- Foundation of the Science and Technology Department of Kaifeng City of Henan Province (2203018)
- Commercial Research Funds with Vectura Fertin Pharma (HX20240114)
- Foundation of the KeyLab of Medical Molecular Cell Biology of Shanxi Province and Shanxi University (MMCB-OP-2023-03)
- the Foundation for Young Scholars in the School of Stomatology of Henan University (HUSSYS2024005)
This publication has 141 references indexed in Scilit:
- Cannabidiol and Liver Enzyme Level Elevations in Healthy AdultsJAMA Internal Medicine, 2025
- Enhancement of cannabidiol oral bioavailability through the development of nanostructured lipid carriers: In vitro and in vivo evaluation studiesDrug Delivery and Translational Research, 2024
- Therapeutic potentials of cannabidiol: Focus on the Nrf2 signaling pathwayBiomedicine & Pharmacotherapy, 2023
- Protective effect and mechanism of cannabidiol on myocardial injury in exhaustive exercise training miceChemico-Biological Interactions, 2022
- The antimicrobial effect behind Cannabis sativaPharmacology Research & Perspectives, 2021
- Impact of conformational and solubility properties on psycho-activity of cannabidiol (CBD) and tetrahydrocannabinol (THC)Chemical Data Collections, 2020
- Cannabidiol protects livers against nonalcoholic steatohepatitis induced by high‐fat high cholesterol diet via regulating NF‐κB and NLRP3 inflammasome pathwayJournal of Cellular Physiology, 2019
- Effects of cannabidiol, a Cannabis sativa constituent, on oral wound healing process in rats: Clinical and histological evaluationPhytotherapy Research, 2018
- In vivo and In vitro Identification of Endocannabinoid Signaling in Periodontal Tissues and Their Potential Role in Local PathophysiologyCellular and Molecular Neurobiology, 2017
- Cannabinoids for Medical UseJAMA, 2015